Trademark: TRUVADA EMTRICITABINE 200 MG / TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
TRUVADA EMTRICITABINE 200 MG / TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS
Proof of use for TRUVADA EMTRICITABINE 200 MG / TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS
We do not have any records of a proof of use for TRUVADA EMTRICITABINE 200 MG / TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS at this moment.
Possible trademark infringements of TRUVADA EMTRICITABINE 200 MG / TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS
Basic Information about TRUVADA EMTRICITABINE 200 MG / TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS
- Serial Number
- 87227314
- Filing Date
- 04 Nov 2016
- Registration Number
- 5623246
- Registration Date
- 04 Dec 2018
- Mark Drawing Code
- 3
Classifications
Declare the trademark use of TRUVADA EMTRICITABINE 200 MG / TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS on the blockchain with WikiTrademarks.io.
- First use of TRUVADA EMTRICITABINE 200 MG / TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS anywhere
- TRUVADA EMTRICITABINE 200 MG / TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS was first used on 31 Mar 2018 for the primary classification of goods and services, international, 035 (Advertising and business)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 035
- US Codes
- 100; 101; 102
- First use of TRUVADA EMTRICITABINE 200 MG / TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS anywhere
- TRUVADA EMTRICITABINE 200 MG / TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS was first used on 31 Mar 2018 for the primary classification of goods and services, international, 044 (Medical, beauty & agricultural)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 044
- US Codes
- 100; 101
Who owns TRUVADA EMTRICITABINE 200 MG / TENOFOVIR DISOPROXIL FUMARATE 300 MG TABLETS FOR PREP PRE-EXPOSURE PROPHYLAXIS?
1. Gilead Sciences, Inc. Foster City CA
2. Gilead Sciences, Inc. Foster City CA
3. Gilead Sciences, Inc. Foster City CA
Correspondent
- Jack Wessel
- Gilead Sciences, Inc.
- 333 Lakeside Drive
- Foster City,CA 94404
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io